Results 71 to 80 of about 2,858 (200)

Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus: systematic review and meta‐analysis of clinical outcomes from non‐randomized studies

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 3, Page 272-282, March 2026.
ABSTRACT Objective Complete hydatidiform mole and coexisting normal fetus (CHMCF) is a rare condition for which there is significant heterogeneity in diagnosis, counseling and management of complications. The objective of this study was to summarize the prevalence of clinical outcomes in reported cases of CHMCF.
N. Salmeri, A. Pizzetti, E. Grassi, R. Cioffi, G. Mangili, M. Seckl, A. Sotiriadis, M. Candiani, P. I. Cavoretto   +8 more
wiley   +1 more source

Toward risk‐stratified management of placental site nodules with atypical features

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1640-1640, August 2026.
Tingting Xu, Shuhong Li
wiley   +1 more source

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 25-50, January 2026.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox, Rosinder Kaur, Kugajeevan Vigneswaran, Rachel Small, Jenny Carter, Keelin O'Donoghue, Alexander E. P. Heazell, Anna L. David, Nigel Simpson, Angharad Care, Lisa Starrs, Andrew Shennan, Catalina María Valencia González, Priya Soma‐Pillay, Leah Fitzsimmons, Adam J. Devall, Arri Coomarasamy, Mid‐trimester Pregnancy Loss Guideline Consensus Panel, Owen Arthurs, Ruth Bender‐Atik, Phil Bennett, Kirstien Boelaert, Elizabeth Bonney, Leanna Brace, Naomi Carlisle, Davide Casagrandi, Manju Chandiramani, Carolyn Chiswick, Alexandra Emms, Stella Fielder, James Goadsby, Laura Goodfellow, Jim Gray, Jemma Johns, Emma Kirk, Will Lester, Sophie Mackay, Maria Memtsa, Katie Morris, Sunbal Mukhtar, Naimah Raza, Rita Sarquis, Neil Sebire, Lucy Smith, Lucy Spencer, Amos Tetteh, Natalie Woodhead   +46 more
wiley   +1 more source

Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: retrospective Analysis From the MITO-9 Group

, 2018
Gestational trophoblastic neoplasia affects women of reproductive age and is usually treated by chemotherapy. Major concerns related to chemotherapy in young women are the possible infertility, risk of early menopause, and teratogenic effects on ...
Petrone, Micaela, Bergamini, Alice, Veronica Giorgione, Emanuela Rabaiotti, Gennaro Cormio, Massimo Candiani, Cormio, Gennaro, Giorgione, Veronica, Rabaiotti, Emanuela, Francesca Pella, Giorgia Mangili, Micaela Petrone, Pella, Francesca, Mangili, Giorgia, Gadducci, Angiolo, Raffaella Cioffi, Alice Bergamini, Candiani, Massimo, Angiolo Gadducci, Cioffi, Raffaella   +19 more
core   +1 more source

Understanding and management of gestational trophoblastic disease [version 1; peer review: 2 approved]

F1000Research, 2019
Gestational trophoblastic disease or neoplasia covers a spectrum of benign and malignant conditions arising from pregnancies with highly abnormal development of trophoblastic tissue.
Fen Ning, Houmei Hou, Abraham N. Morse, Gendie E. Lash   +3 more
doaj   +1 more source

Optimizing Maternal Microbiome: Role in Improved Conception and Pregnancy Outcome

Reproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
Maternal microbiome optimization: Minimized risk and simple corrective steps. ABSTRACT Purpose To evaluate the role of optimizing the maternal microbiome in improving pregnancy outcomes, focusing on preconception and early gestation, and to propose practical diagnostic and preventive strategies, particularly in low‐ and middle‐income countries (LMIC ...
Eytan R. Barnea, Amala Nazareth, Chittaranjan N. Purandare, Anderson Pinheiro‐Borovac, Ruth Dolmo Carluccio, Nikhil C. Purandare, Fionnuala M. McAuliffe, FIGO Reproductive Endocrinology and Infertility Committee Members   +7 more
wiley   +1 more source

Partial Invasive Mole with Bilateral Torsion of Theca Lutein Cysts

Journal of Nepal Health Research Council, 2018
Gestational trophoblastic neoplasia is extremely rare entity accounting 1% of all gynecological malignancies. Invasive mole is a form of Gestational trophoblastic neoplasia which is locally invasive with propensity of metastasis.
Randhir Sagar Yadav, Shumneva Shrestha, Santosh Sharma, Meeta Singh, Kesang Diki Bista, Neebha Ojha   +5 more
doaj   +1 more source

Whole‐genome paternal uniparental disomy identified through prenatal single‐nucleotide polymorphism‐based cell‐free DNA screening

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 1, Page 73-78, January 2026.
ABSTRACT Objective Prenatal single‐nucleotide polymorphism (SNP)‐based cell‐free DNA (cfDNA) screening can identify genome‐wide paternal uniparental disomy (GW‐UPDpat), including cases with complete hydatidiform mole with a coexisting fetus (CHMCF), those with placental mesenchymal dysplasia (PMD) and those with a mosaic/chimeric GW‐UPDpat syndrome ...
P. Benn, K. Hashimoto, V. Souter, R. Dhamankar, W. Xu, D. Kijacic   +5 more
wiley   +1 more source

A comparative study of the efficiency and safety of chemotherapy as a therapeutic method for recurrent or resistant gestational trophoblastic neoplasia: a protocol for systematic review and meta-analysis

, 2021
Background: Gestational trophoblastic neoplasia represents a rare placental malignancy spectrum that is treated with single-agent or multi-agent chemotherapy.
Xiaoling Feng
core   +1 more source

Abdominal Hysterectomy Under Thoracic Epidural Anesthesia for Complete Molar Pregnancy in a Patient With Atypical Preeclampsia and Hyperthyroidism in a Resource‐Limited Setting: Case Report and Literature Review

Case Reports in Anesthesiology, Volume 2026, Issue 1, 2026.
Background Hydatidiform mole is a rare gynecological disease arising from trophoblastic tissue. There is no standard anesthetic management for patients undergoing major abdominal surgery; the decision may be based on preoperative patient status, the presence of coexisting illnesses, the risk of aspiration, and the availability of advanced equipment ...
Mesay Milkias, Semagn Mekonnen, Fikru Milkiyas, Mebratu Kebede, Nigatu Tilahun, Srijoni Sengupta   +5 more
wiley   +1 more source